unknown by Hunaid A Vohra & Manuel Galiñanes
BioMed CentralBMC Physiology
ssOpen AcceResearch article
Effect of the degree of ischaemic injury and reoxygenation time on 
the type of myocardial cell death in man: role of caspases
Hunaid A Vohra and Manuel Galiñanes*
Address: Cardiac Surgery Unit, Department of Cardiovascular Sciences, University of Leicester Leicester, UK
Email: Hunaid A Vohra - hunaidvohra@yahoo.co.uk; Manuel Galiñanes* - mg50@le.ac.uk
* Corresponding author    
Abstract
Background: The importance of apoptosis in the injury sustained by the human myocardium
during ischaemia and reoxygenation and the underlying mechanisms remain unclear. To quantify
apoptosis and necrosis induced by simulated ischaemia/reoxygenation in the human atrial
myocardium, free-hand sections of right atrial appendage (n = 8/group) were subjected to 90
minutes simulated ischaemia followed by 2, 8 and 24 hours reoxygenation.
Results: Apoptosis, as assessed by TUNEL, was greater than necrosis after 90 minutes simulated
ischaemia and 2 hours reoxygenation (35.32 ± 3.22% vs 13.55 ± 1.3%; p < 0.05) but necrosis was
greater than apoptosis by 24 hours reoxygenation (45.20 ± 2.75% vs 4.82 ± 0.79%; p < 0.05). Total
caspase activation was similar after 90 minutes simulated ischaemia followed by 2 hours and 24
hours reoxygenation (515270 ± 99570 U vs 542940 ± 95216 U; p = NS). However, caspase-3 like
activation was higher at 2 hours than at 24 hours reoxygenation (135900 ± 42200 U vs 54970 ±
19100 U; p < 0.05). Inhibition of caspase-3 by z.DEVD.fmk (70 nM) almost completely abolished
apoptosis from 23.26 ± 2.854% to 0.73 ± 0.28 % (p < 0.05), without affecting necrosis.
Conclusion: Cell death by apoptosis and necrosis in the human myocardium subjected to
simulated ischaemia/reoxygenation depends on the degree of the ischaemic insult and have a
different time-course with apoptosis happening early during reoxygenation and necrosis becoming
more important later. Importantly, the apoptosis induced by simulated ischaemia/reoxygenation is
mainly mediated by activation of caspase-3 but it does not affect necrosis.
Background
Ischaemia/reoxygenation of the heart induces apoptosis
and necrosis [1-4]; however, the actual contribution of
these two forms of cell death to ischaemia/reoxygenation
injury and their time-course have not been established in
the human myocardium and remains controversial in
experimental animal models. Kajstura et al [3] have
reported that apoptosis begins in rat ischaemic myocar-
dium either after a prolonged period of permanent ischae-
mia or during a much shorter period of ischaemia
followed by reperfusion whereas others [1,2] have shown
that although apoptosis may be initiated during ischae-
mia, its detection is increased and may well be accelerated
during reperfusion. On the other hand, studies in a dog
model of coronary artery ligation have shown that necro-
sis, quantified histologically, develops rapidly after
ischaemia and is directly proportional to the ischaemic
time [5], although, there is evidence in the literature sug-
gesting that necrosis may also result secondary to reper-
fusion injury [4]. Furthermore, it has also been suggested
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cal levels of ATP [6,7].
The mechanisms of ischaemia/reoxygenation injury have
been extensively investigated, however its pathophysiol-
ogy is complex and the involvement and importance of
various pathways such as the caspases remains unclear.
The aims of the present studies were: (i) to investigate the
degree and the time-course of apoptosis and necrosis sus-
tained during ischaemia and reoxygenation of the human
myocardium and (ii) to examine the role of caspase acti-
vation. Here we have demonstrated that the type of cell
death induced by simulated ischaemia/reoxygenation of
the human myocardium depends on the ischaemic insult
with apoptosis happening early during reoxygenation and
necrosis becoming more important later. In addition, the
present studies have shown the apoptosis induced by sim-
ulated ischaemia/reoxygenation is mainly mediated by
activation of caspace-3 but that it does not affect necrosis.
Results
Study 1: Effect of the intensity of ischaemic injury and the 
time of reoxygenation
(i) Apoptosis and necrosis
Figure 1 shows a low degree of apoptosis and necrosis in
muscles aerobically incubated for 2 hours (3.2 ± 1.3% and
2.8 ± 0.8%, respectively) and further increases of the two
forms of cell death with the extension of aerobic incuba-
tion to 8 and 24 hours. As expected, the degree of necrosis
increased with extension of ischaemia, however apoptosis
was greater than necrosis (32.0 ± 3.2% vs 10.7 ± 1.9; p <
0.05) after 90 minutes of ischaemia and two hours of
reoxygenation and the reverse was seen after 180 minutes
of ischaemia (12.6 ± 1.9% vs 27.1% ± 2.8%; p < 0.05). A
similar cell death pattern was observed after 8 hours of
reoxygenation although the extent of apoptosis and
necrosis was greater than after 2 hours of reoxygenation.
After 24 hours of reoxygenation, necrosis also increased
with the extension of ischaemia and it was greater than
after 2 and 8 hours of reoxygenation, but necrosis was sig-
nificantly more important than apoptosis. Figures 2 and 3
depict representative images of fluorescent apoptotic and
necrotic nuclei.
(ii) MTT reduction
Figure 4 shows that there was a decrease in MTT reduction
with increasing periods of ischaemia and that, in contrast
with the assessment of apoptosis and necrosis by the
TUNEL assay, it was not significantly influenced by
increasing the period of reoxygenation.
Percentage of apoptosis (empty columns) and necrosis (solid columns) in right atrial muscles subjected to various periods of simulated ischaemia followed by various periods of reoxygenationFig re 1
Percentage of apoptosis (empty columns) and necrosis (solid columns) in right atrial muscles subjected to various periods of 
simulated ischaemia followed by various periods of reoxygenation. The columns represent the mean of 8 experiments and the 
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Table 1 demonstrates that the CK release exhibited the
lowest values in the aerobic control groups and that there
was an increase in CK release with increasing ischaemia.
The mean CK release values during the first two hours of
reoxygenation were similar in the groups with identical
ischaemic time suggesting that ischaemic injury was of the
same degree in the three reoxygenation protocols
Representative images for apoptosis (TUNEL) in the following protocols: aerobic control (A); 30, 90 and 180 minutes of simu-lated i chaemia followed by 120 minutes of reoxygenation (B, C and D, respectively)Figure 2
Representative images for apoptosis (TUNEL) in the following protocols: aerobic control (A); 30, 90 and 180 minutes of simu-
lated ischaemia followed by 120 minutes of reoxygenation (B, C and D, respectively).
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Figure 5A shows that there was no significant difference in
the total caspase activation irrespective of the time of
ischaemia or reoxygenation amongst the groups and that,
unexpectedly, the highest values corresponded to the
fresh tissue. This activity decreased after 30 minutes of aer-
Representative images for necrosis (propidium iodide) in the following protocols: aerobic control (A); 30, 90 and 180 minutes of simulated ischaemia llowed by 120 min tes of r oxygenation (B, C and D resp ctively)Figure 3
Representative images for necrosis (propidium iodide) in the following protocols: aerobic control (A); 30, 90 and 180 minutes 
of simulated ischaemia followed by 120 minutes of reoxygenation (B, C and D respectively).
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transient increase in total caspase activity is unclear but
was not associated with greater caspase-3 activation (see
below) and was not translated into a rise in apoptosis.
Figure 5B demonstrates that caspase-3-like activation was
significantly increased after 2 hours of aerobic incubation
when compared to the mean values in the fresh muscles
and that although activity increased with the extension of
the ischaemic time, values were not greater than the ones
seen in the aerobic control group. Importantly, by 8 and
24 hours of reoxygenation the levels of caspase-3-like acti-
vation had decreased to levels close to the values observed
in the fresh muscles irrespective of the periods of
ischaemia.
Study 2: The role of caspase activation in cell death
(i) Inhibition of caspase-3 activity
Figure 6 shows that following 90 minutes of simulated
ischaemia and 2 hours of reperfusion there was a dose-
dependent reduction in caspase-3 activity with increasing
concentration of z.DEVD.FMK, and that activity was
almost completely abolished with 70 nM concentration of
the inhibitor.
MTT reduction of right atrial muscles subjected to various periods of simulated ischaemia followed by various periods of reoxyg nationFigure 4
MTT reduction of right atrial muscles subjected to various periods of simulated ischaemia followed by various periods of reox-
ygenation. The columns represent the mean of 8 experiments and the bars represent the SEM. *p < 0.05 vs aerobic control.
Table 1: CK leakage during the first 2 hours of reoxygenation of right atrial muscles (n = 8/group) subjected to various periods of 
simulated ischaemia followed by various periods of reoxygenation as compared with the enzyme leakage of muscles for the first 2 
hours of aerobic incubation. *p < 0.05 vs the respective aerobic controls.
Reoxygenation group Aerobic control Simulated ischaemia (minutes)
30 90 180
2 hours 2.6 ± 0.2 3.5 ± 0.3* 5.0 ± 0.4* 6.4 ± 0.4*
8 hours 2.8 ± 0.3 4.0 ± 0.5* 5.0 ± 0.4* 6.6 ± 0.8*
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Total caspase activity (A) and caspase-3-like activity (B) in right atrial muscles subjected to various periods of simulated ischae-
mia followed by various periods of reoxygenation. The columns represent the mean of 8 experiments and the bars represent 
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Figure 7 shows the percentage of apoptosis and necrosis in
atrial tissue after SI/R in the absence and presence of the
caspase-3 inhibitor z.DEVD.FMK (70 nM). Caspase-3
inhibition significantly reduced apoptosis in the muscles
aerobically incubated and resulted in almost complete
abolition of apoptosis, from 23.3 ± 2.8% to 0.7 ± 0.3% (p
< 0.05), in the muscles subjected to simulated ischaemia/
reoxygenation. Interestingly, z.DEVD.FMK did not influ-
ence the degree of necrosis.
(iii) MTT Reduction
Table 2 shows that there was no significant change in MTT
reduction with the addition of z.DEVD.FMK in the mus-
cles aerobically incubated and those subjected to simu-
lated ischaemia/reoxygenation. Since, as seen above,
apoptosis was almost abolished whereas necrosis was
unaffected by caspase-3 inhibition, these results suggest
that the observed changes in MTT reduction are not a
reflection of apoptosis.
(iv) CK release
Table 2 also shows that the addition of z.DEVD.FMK did
not affect the CK release of the aerobically incubated mus-
cle and that the increase in CK release induced by 90 min-
utes of simulated ischaemia and 2 hours reoxygenation
was unchanged, this suggesting that, as seen with MTT
reduction, changes in CK release are not a reflection of
apoptosis.
Discussion
The present studies have demonstrated that, depending
on the ischaemic insult, apoptosis may be the predomi-
nant form of cell death in the human myocardium during
the first 8 hours of reoxygenation, so that apoptosis is
more important than necrosis when the ischaemic period
is ≤ 90 minutes but the reverse is true after 180 minutes of
ischaemia; however, by 24 hours of reperfusion cell death
by apoptosis has subsided and necrosis, that also depends
on the degree of ischaemia, becomes the leading cause of
cell death. The implications of these findings for the
understanding of the pathophysiology of ischaemia/reox-
ygenation injury are discussed below.
Effect of the degree of ischaemic injury and the duration 
of reoxygenation on the type of cell death
Our study is the first to report on the time-course of cell
death by apoptosis and necrosis induced by ischaemia
Dose-response effect of the caspase-3 inhibitor z.DEVD.FMK on caspase-3 activitiy of atrial muscles subjected to 90 minutes of simulat d ischaemia follow d by 120 minutes of reoxygenationFig re 6
Dose-response effect of the caspase-3 inhibitor z.DEVD.FMK on caspase-3 activitiy of atrial muscles subjected to 90 minutes of 
simulated ischaemia followed by 120 minutes of reoxygenation. Data are expressed as the mean of 4 experiments and the bars 
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onstration that apoptosis follows a bell-shaped profile,
increasing with the duration of ischaemia up to 90
minutes and then decreasing by 180 minutes of ischae-
mia, is novel. Previous experimental studies could not
show this response because they used limited time-peri-
ods of ischaemia [1,8,9]. The finding that apoptosis
increases with the duration of reoxygenation from 2 to 8
hours is supported by observations in the dog heart sub-
jected to 60 minutes of ischaemia and reperfused for 6,
24, 48 and 72 hours [9]. However, whilst our study
showed a decline in apoptosis when the myocardium was
reoxygenated for 24 hours, the latter study [9] reported a
progressive increase in apoptosis over the 72 hours of
reperfusion. The reason for the differing results of the two
studies is unclear but the use of different species (e.g., man
Effect of caspase-3 inhibition (C3i) with z.DEVD.FMK (70 nM) on apoptosis (empty columns) and necrosis (solid columns) in right atrial mu cles subjected to 90 minutes of simulated ischaemi  and 2 hours of re xygenationFigure 7
Effect of caspase-3 inhibition (C3i) with z.DEVD.FMK (70 nM) on apoptosis (empty columns) and necrosis (solid columns) in 
right atrial muscles subjected to 90 minutes of simulated ischaemia and 2 hours of reoxygenation. The columns represent the 
mean of 6 experiments and the bars represent the SEM. *p < 0.05 vs corresponding group without caspase-3 inhibitor.
Table 2: CK leakage during the first 2 hours of reoxygenation and MTT reduction at the end of the reoxygenation period of right atrial 
muscles (n = 6/group) after 90 minutes of simulated ischaemia/reoxygenation (SI/R) in the presence and absence of the caspase-3 
inhibitor z.DEVD.FMK (70 nM).
Group MTT P value CK P value
Aerobic Control 290.3 ± 32.3 2.5 ± 0.2
Aerobic Control plus C3i 298.0 ± 30.4 NS 2.7 ± 0.1 NS
SI/R 212.7 ± 23.1 5.4 ± 0.4
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versus in vivo) may be, at least in part, responsible.
The present studies have also shown that, as expected, the
degree of cell death by necrosis is directly proportional to
the severity of ischaemia. But, in addition, they have dem-
onstrated that necrosis gradually increases with the dura-
tion of reoxygenation, which is consistent with the
observation that necrosis is a dynamic process that contin-
ues over a period of at least 24 hours of reperfusion [9]. It
should be mentioned, however, that the degree of tissue
injury as assessed by the reduction of MTT was not
increased with the duration of reoxygenation. This appar-
ent contradiction between the results obtained with the
propidium iodide staining and MTT reduction is not clear,
but it is possible that while the former reflects the extent
of necrosis alone, the latter may represent other forms of
cell death. The lack of agreement of these two assays
highlights the importance of using more than one index
to assess tissue injury.
Role of caspase activation on ischaemia/reoxygenation-
induced cell death
The similar mean values of total caspase activity seen after
all studied ischaemic and reoxygenation periods may sug-
gest that this pathway may not be an important mecha-
nism of cell death in the human myocardium or, more
likely, that only specific caspases may take part in this
process, the changes of which may not be of sufficient
magnitude to significantly alter the whole pool of cas-
pases. Our finding that caspase-3 activity is increased by
the degree of ischaemic insult would support the latter
hypo-thesis. The rapid dissipation of caspase-3 activity
with the extension of the reoxygenation period suggests
that this enzyme may be activated for a limited time
period and that, therefore, the time points investigated in
our studies do not provide a complete time-course of
changes in enzyme activity. A participation of caspases in
apoptosis has also been observed in experimental animal
studies [10], with elevation of caspase-3 activity during
the early reperfusion period [11,12]. It is of interest to
note that in the present studies total caspase activity, but
not caspase-3 activity, was elevated in fresh tissue, a
finding that may be explained by the handling and
mechanical injury sustained during the sectioning of the
muscle.
The almost complete abolition of apoptosis by the spe-
cific caspase-3 inhibitor z.DEVD.FMK seen in our studies
demonstrates that the induction of apoptosis by ischae-
mia/reoxygenation in the human myocardium is caspase-
3 dependent. This finding in man is supported by in vitro
and in vivo animal experimental studies [13,14] in which
caspase-3 inhibition attenuated apoptosis and reduced
reperfusion injury, all suggesting that caspase-3 activation
is an obligatory step in the signal transduction pathway of
apoptosis induced by ischaemia/reoxygenation. However,
necrosis was unaffected by caspase-3 inhibition, which
agrees with results reported in adult rat ventricular myo-
cytes [12], although it has been observed that in cancer
cells caspase inhibitors also retard necrosis in an in vitro
model of chemical hypoxia [7].
Although these studies did not address the mechanism of
caspase-3 activation, it has been previously shown that
caspases can be activated by oxidative stress [15], an
important element of ischaemia/reoxygenation injury.
Furthermore, the apoptosis elicited by oxidative stress can
be reduced by the opening of mitoKATP channels [16] and
the apoptosis and caspase-3 activation induced by ischae-
mia/reoxygenation can be reduced by overexpression of
the heat shock proteins HSP-60 and HSP-10 [17]. It is
clear that more investigation is required to elucidate the
signalling pathway leading to activation of caspase-3 dur-
ing ischaemia/reoxygenation.
Study limitations
In the present studies the human atrial tissue was used
and therefore any extrapolation to the ventricular
myocardium should be made with caution. Thus, for
example, KATP channels that play a role in ischaemic injury
exist in both atrium and ventricle [18], although their dis-
tribution differs in the two cardiac chambers [19].
Another potential limitation of these studies is that
ischaemia and reperfusion were simulated by artificial
means instead of using arterial occlusion and release,
however, the avoidance of the confounding effects of col-
lateral flow with our preparation could be advantageous.
The model of simulated ischaemia and reoxygenation
used in the present studies was characterised in our labo-
ratory [20] and subsequently has been used for the inves-
tigation of the mechanism of ischaemic and
pharmacological preconditioning in man [21-25].
Conclusion
Here we have shown that cell death by apoptosis and
necrosis in the human myocardium subjected to
ischaemia and reoxygenation depends on the degree of
the ischaemic insult and have a different time-course with
apoptosis happening early during reoxygenation and
necrosis becoming more important later. They also have
shown that caspase-3 activation plays a critical role in
apoptosis but that it does not affect necrosis.
Methods
Patients
The right atrial appendage from patients undergoing elec-
tive coronary artery bypass graft surgery was retrieved at
the time of the right atrial cannulation. For this, local eth-
ical approval and patients' informed consent wasPage 9 of 12
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fraction (EF < 30%), and those with diabetes and taking
potassium channel openers (nicorandil or diazoxide)
were excluded.
Experimental preparation and solutions
The sectioning of the atrial muscle and the preparation of
simulated ischaemia/reoxygenation have been previously
described [20]. Briefly, the appendage was mounted onto
an ice cooled ground glass plate with the epicardial sur-
face face down and then sliced freehand with surgical skin
graft blades (Shwann-Morton, UK) to a thickness of
between 300 and 500 µm. Muscle sections weighing
between 30–50 mg were then transferred to conical flasks
(25 ml Erlenmeyer flasks, Duran, Astell Scientific, Sidcup,
Kent, UK) containing 10 ml of oxygenated buffered solu-
tion. Following this, the flasks were placed in a shaking
water bath maintained at 37°C. The oxygenation of the
incubation medium was maintained by a continuous flow
of 95% O2/5%CO2 gas mixture to obtain a pO2 between
25 and 30 kPa and a pCO2 between 6.0 and 6.5 kPa. These
sections were equilibrated for 30 minutes in oxygenated
Krebs Henseleit Hepes (KHH) buffer containing (in mM):
NaCl (118), KCl (4.8), NaHCO3 (27.2), MgCl2 (1.2),
KH2PO4 (1.0), CaCl2 (1.20), glucose.H2O (10), HEPES
(20) at a pH of 7.4 and a temperature of 37°C. The buffer
was supplemented with 10% foetal calf serum (FCS: Har-
lanseralabs #S-0001A). Ischaemia was simulated by bub-
bling the media with 95% N2 and 5% CO2 in the absence
of glucose (pH 6.6–6.9).
Experimental protocols
Study 1: Effect of the intensity of ischaemic injury and the time of 
reoxygenation
After being equilibrated in oxygenated KHH buffer for 30
minutes, the atrial sections were randomly allocated to
various protocols: 30, 90 and 180 minutes of ischaemia
followed by 2, 8 or 24 hours of reoxygenation (n = 8/
group). Some slices were not subjected to ischaemia and
were aerobically incubated for 2, 8 or 24 hours to serve as
aerobic controls. Creatine kinase (CK) release into the
media was measured during the first 2 hours of reoxygen-
ation and during the first 2 hours of aerobic incubation in
the controls. The tissues were taken at the end of the pro-
tocols for the assessment of tissue viability, cell necrosis
and apoptosis, and caspase activity (see below).
Study 2: The role of caspase activation in cell death
Free-hand sections of fresh atrial tissue were allowed to
equilibrate in oxygenated KHH buffer for 30 minutes and
then subjected to 90 minutes of simulated ischaemia fol-
lowed by 120 minutes of reoxygenation (n = 4/group) in
the absence (controls) and presence of 0.7, 7.0 and 70.0
nM concentrations of the specific caspase-3 inhibitor
z.DEVD.FMK. The inhibitor was present in the media
throughout the entire experimental protocol. The tissue
was taken at the end of protocol and stored at -80°C until
assessment of caspase-3 activity.
In an additional study, the atrial muscles (n = 6/group)
were subjected to the following experimental protocols:
(i) aerobic perfusion for 240 minutes; (ii) aerobic per-
fusion for 240 minutes with the caspase inhibitor
z.DEVD.FMK (70 nM); (iii) 90 minutes simulated ischae-
mia followed by 120 minutes reoxygenation; and (iv)
simulated ischaemia/reoxygenation with 70 nM
z.DEVD.FMK (70 nM). The caspase inhibitor was incu-
bated with the muscles for the entire experimental period.
As before, the CK release was measured in the incubation
media during the 120 minutes of reoxygenation or during
the last 120 minutes of aerobic incubation in the controls
and the tissue was taken at the end of protocols for the
assessment of tissue viability and cell necrosis and
apoptosis.
Assessment of tissue injury and viability
CK release into the perfusate during the 2 hours of reoxy-
genation was measured as an index of tissue injury. The
enzyme activity was measured by a linked-enzyme kinetic
assay employing a commercial assay kit (DG147-K: Sigma
Chemicals, Perth, Australia) and expressed as IU/g wet
weight.
Tissue viability was assessed by the mitochondrial reduc-
tion of 3-[4,5 dimethylthiazol-2-y1]-2,5 diphenyltetrazo-
lium bromide (MTT) to an insoluble purple formazan dye
(M2128-Sigma Chemicals, Perth, Australia) at the end of
the reoxygenation period, as previously described [26].
Finally, the absorbance of the blue formazan product was
measured on a plate reader (Benchmark, Bio-Rad Labora-
tories, Hercules, CA, USA) at 550 nm and the results were
expressed as mM of formazan/g wet weight.
Assessment of apoptosis and necrosis
The muscles were incubated for 10 minutes on ice with 5
µM propidium iodide (PI) in 0.1 M tri-sodium citrate and
20 mM phosphate buffered saline (PBS) at pH7.4 to
identify the necrotic nuclei. Sections were then fixed
twice, first for 30 minutes then with 4% paraformalde-
hyde in 30% sucrose and 20 mM PBS overnight on ice and
at pH7.4. Following this, serial sections of 10 µm were cut
with a Bright cryomicrotome (model OTF) at -25°C in tis-
sue embedding matrix (Tissue Tek® OCT compound). Mir-
ror sections were labelled at this stage with 20 µM PI to
stain the total number of nuclei in each section. The cryo-
preserved tissue sections were washed with 20 mM PBS at
pH 7.4 for 2 minutes, then permeabilised in 0.02 mg/ml
proteinase-K for 10 min at 37Cs, and pre-sensitised for 1
minute in a microwave oven at 800 watts in 0.1% Triton
X-100 and 0.1 M sodium citrate at pH 6.0. To assess apop-Page 10 of 12
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used to incorporate fluorescein (FITC) labelled dUTP oli-
gonucleotides to DNA strand breaks at the 3'-OH termini
in a template dependent manner (TUNEL technique)
using a commercially available kit (Roche: 1684795,
Basel, Switzerland). The FITC fluorescence emission
(range 600–630 nm) was measured using argon-ion fluo-
rescence excitation at 488 nm and detected by laser
confocal epifluorescence microscopy with a ×10 oil
immersion objective. The PI labelled nuclei was excited
with helium-neon laser light at 543 nm and fluorescence
was detected using an emission range of 680–730 nm in
order to abolish fluorescence 'bleed-through' from FITC
labelled nuclei. Analysis was done using NIH Image soft-
ware (Scion Corp, Frederick, Maryland, USA) with the
Cavalieri-3 macro (G. MacDonald, University of Washing-
ton). Fluorescent signals with areas greater than 16 µm2
were counted to ensure that only cardiomyocyte nuclei are
taken into account and to avoid the inclusion of artefact.
Quantitation of caspase activity
The muscle sections stored at -80°C until analyses were
thawed in 400 µl of cell lysis buffer (in mM: Hepes (100),
10% sucrose, 0.1% Chaps and DTT (10), in the presence
of a cocktail of enzyme inhibitors (P2850-Sigma Chemi-
cals, Perth, Australia) at a pH of 7.0 to release the intracel-
lular contents. The sections were diced finely and then
homogenised (Ultra-Turrax homogeniser: Janke and Kun-
kel GmbH, Staufen, Germany) at 13,000 rpm for 1
minute on ice. This was followed by centrifugation
(PK121R-ALC International) at 14,000 rpm for 30 min-
utes. Subsequently, the protein concentration of the solu-
ble supernatant (cell lysate) was measured using a
detergent compatible Bio-Rad assay (23225-Pierce,
Cheshire, UK). Aliquots of cell lysate were then tested for
caspase activity by the addition of the caspase-specific
substrate DEVD, that is conjugated to the chromophore
(fluorescent reporter molecule) 7-amino-4-trifluorome-
thyl coumarin (AFC). The cleavage of the peptide DEVD
from DEVD.AFC (final concentration 20 µM;Alexis
Chemicals, San Diego, CA, USA) releases AFC that when
excited by light at 400 nm emits fluorescence at 505 nm.
The level of caspase activity in the cell lysate is detected by
fluorescence signal obtained with a fluorometer (Fluostar
P401, BMG software, Longmont, CO, USA). The amount
of caspase-3 like activity was measured by using the effec-
tor caspase inhibitor z.DEVD.FMK at a final concentration
of 10 µM in the well of the reader plate and by subtracting
the fluorescence obtained in the presence of the inhibitor
by the total fluorescence measured in the absence of the
inhibitor. The inherent fluorescence of the aromatic resi-
dues in the protein homogenate was subtracted in the
final calculations. The results were expressed as units of
activity/g wet weight.
Statistical analyses
Data were expressed as mean ± SEM. ANOVA was used for
comparisons of means (Microsoft® Excel analysis tool
pak) with the application of a post-hoc Tukey's test. A p
value of less than 0.05 was considered statistically
significant.
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